Reply to the Letter to the Editor 'There is no place for ovarian cancer screening in hereditary breast-ovarian cancer syndromes (in regard to "ESMO Clinical Practice Guideline on risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes")' by W. Tjalma

Ann Oncol. 2024 Jan;35(1):139-140. doi: 10.1016/j.annonc.2023.10.119. Epub 2023 Oct 28.
No abstract available

Publication types

  • Letter

MeSH terms

  • Breast Neoplasms* / diagnosis
  • Breast Neoplasms* / genetics
  • Breast Neoplasms* / prevention & control
  • Early Detection of Cancer
  • Female
  • Humans
  • Neoplastic Syndromes, Hereditary*
  • Ovarian Neoplasms* / diagnosis
  • Ovarian Neoplasms* / genetics
  • Ovarian Neoplasms* / prevention & control
  • Risk Reduction Behavior

Supplementary concepts

  • Breast Cancer, Familial